본문 바로가기
KERD
논문KCI 등재

Type 2 Autoimmune Pancreatitis: Consensus and Controversies

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Autoimmune pancreatitis (AIP) has attracted much attention in the last two decades, and due to the diagnostic value of immunoglobulin G4 (IgG4), the number of cases diagnosed in clinical practice has markedly increased. However, in contrast to prototypic IgG4-related type 1 AIP, a minor subtype of AIP, referred to as type 2 AIP, is less widely known and has thus not yet been characterized in detail. Type 2 AIP is unrelated to IgG4 and is a completely distinct entity from type 1 AIP. One confusing factor is that the two types of AIP share patterns of clinical presentation (e.g., acute pancreatitis and painless jaundice) and imaging abnormalities (e.g., diffuse or segmental enlargement). Since there are currently no established serum markers, the diagnosis of type 2 AIP is highly challenging and requires the tissue confirmation of neutrophilic injury to the pancreatic ducts, a finding designated as a granulocytic epithelial lesion. Approximately one-third of cases are associated with inflammatory bowel disease, particularly ulcerative colitis; however, the pathological relationship between these two conditions has not yet been clarified. Unanswered questions relate to its pathophysiology, the potential development of a similar granulocytic injury in other organs, and the characteristics of pediatric cases. This review summarizes consensus and controversies surrounding type 2 AIP, with the aim of increasing awareness and highlighting the unmet needs of this underrecognized condition.

Abstract

Autoimmune pancreatitis (AIP) has attracted much attention in the last two decades, and due to the diagnostic value of immunoglobulin G4 (IgG4), the number of cases diagnosed in clinical practice has markedly increased. However, in contrast to prototypic IgG4-related type 1 AIP, a minor subtype of AIP, referred to as type 2 AIP, is less widely known and has thus not yet been characterized in detail. Type 2 AIP is unrelated to IgG4 and is a completely distinct entity from type 1 AIP. One confusing factor is that the two types of AIP share patterns of clinical presentation (e.g., acute pancreatitis and painless jaundice) and imaging abnormalities (e.g., diffuse or segmental enlargement). Since there are currently no established serum markers, the diagnosis of type 2 AIP is highly challenging and requires the tissue confirmation of neutrophilic injury to the pancreatic ducts, a finding designated as a granulocytic epithelial lesion. Approximately one-third of cases are associated with inflammatory bowel disease, particularly ulcerative colitis; however, the pathological relationship between these two conditions has not yet been clarified. Unanswered questions relate to its pathophysiology, the potential development of a similar granulocytic injury in other organs, and the characteristics of pediatric cases. This review summarizes consensus and controversies surrounding type 2 AIP, with the aim of increasing awareness and highlighting the unmet needs of this underrecognized condition.

참고문헌 (50)

  1. Notohara K, "Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration : clinicopathologic features of 35 cases", Am J Surg Pathol, 27, pp.1119~1127 (2003)
  2. Zamboni G, "Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis : a study on 53 resection specimens and 9 biopsy specimens", Virchows Arch, 445, pp.552~563 (2004)
  3. Chari ST, "Histopathologic and clinical subtypes of autoimmune pancreatitis : the Honolulu consensus document", Pancreas, 39, pp.549~554 (2010)
  4. Hart PA, "Long-term outcomes of autoimmune pancreatitis : a multicentre, international analysis", Gut, 62, pp.1771~1776 (2013)
  5. Hart PA, "Recent advances in autoimmune pancreatitis", Gastroenterology, 149, pp.39~51 (2015)
  6. Hart PA, "Clinical profiles and outcomes in idiopathic duct-centric chronic pancreatitis(type 2autoimmune pancreatitis) : the Mayo Clinic experience", Gut, 65, pp.1702~1709 (2016)
  7. 오동욱, "Type 2 Autoimmune Pancreatitis (Idiopathic Duct-Centric Pancreatitis) Highlighting Patients Presenting as Clinical Acute Pancreatitis: A Single- Center Experience", Gut and Liver, 13(4), pp.461~470 (2019), 거트앤리버 소화기연관학회협의회[DOI]
  8. Ghazale A, "Value of serum IgG4in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer", Am J Gastroenterol, 102, pp.1646~1653 (2007)
  9. Inoue D, "IgG4-related disease:dataset of 235 consecutive patients", Medicine(Baltimore), 94, pp.e680~ (2015)
  10. Zen Y, "Autoimmune pancreatitis in children : insights into the diagnostic challenge", J Pediatr Gastroenterol Nutr, 59, pp.e42~e45 (2014)
  11. Kamisawa T, "IgG4-related disease", Lancet, 385, pp.1460~1471 (2015)
  12. Kamisawa T, "Advances in IgG4-related pancreatobiliary diseases", Lancet Gastroenterol Hepatol, 3, pp.575~585 (2018)
  13. de Pretis N, "Autoimmune pancreatitis type 2", Curr Opin Gastroenterol, 36, pp.417~420 (2020)
  14. Lorenzo D, "Features of autoimmune pancreatitis associated with inflammatory bowel diseases", Clin Gastroenterol Hepatol, 16, pp.59~67 (2018)
  15. Shimosegawa T, "International consensus diagnostic criteria for autoimmune pancreatitis : guidelines of the International Association of Pancreatology", Pancreas, 40, pp.352~358 (2011)
  16. Kanno A, "Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2011", Pancreas, 44, pp.535~539 (2015)
  17. Zen Y, "Tumefactive inflammatory diseases of the pancreas", Am J Pathol, 189, pp.82~93 (2019)
  18. Zhang L, "Autoimmune pancreatitis(AIP)type 1 and type 2 : an international consensus study on histopathologic diagnostic criteria", Pancreas, 40, pp.1172~1179 (2011)
  19. Khandelwal A, "Autoimmune pancreatitis:an update", Abdom Radiol(NY), 45, pp.1359~1370 (2020)
  20. Zhang L, "IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis", Mod Pathol, 20, pp.23~28 (2007)
  21. Zen Y, "IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis : do they belong to a spectrum of sclerosing pancreatitis", Am J Surg Pathol, 28, pp.1193~1203 (2004)
  22. Deshpande V, "Consensus statement on the pathology of IgG4-related disease", Mod Pathol, 25, pp.1181~1192 (2012)
  23. Negrelli R, "Type 1 and type 2autoimmune pancreatitis : distinctive clinical and pathological features, but are there any differences at magnetic resonance? Experience from a referral center", Pancreas, 47, pp.1115~1122 (2018)
  24. Manfredi R, "Autoimmune pancreatitis : pancreatic and extrapancreatic MR imaging-MR cholangiopancreatography findings at diagnosis, after steroid therapy, and at recurrence", Radiology, 260, pp.428~436 (2011)
  25. Negrelli R, "Pancreatic duct abnormalities in focal autoimmune pancreatitis : MR", MRCP imaging findings, 2015, pp.25, 359~367
  26. Takahashi N, "Dual-phase CT of autoimmune pancreatitis : a multireader study", AJR Am J Roentgenol, 190, pp.280~286 (2008)
  27. Takahashi N, "Autoimmune pancreatitis : differentiation from pancreatic carcinoma and normal pancreas on the basis of enhancement characteristics at dual-phase CT", AJR Am J Roentgenol, 193, pp.479~484 (2009)
  28. Park SH, "The characteristics of ulcerative colitis associated with autoimmune pancreatitis", J Clin Gastroenterol, 47, pp.520~525 (2013)
  29. Sah RP, "Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis", Gastroenterology, 139, pp.140~148 (2010)
  30. de Pretis N, "Autoimmune pancreatitis not otherwise specified(NOS) : clinical features and outcomes of the forgotten type", Hepatobiliary Pancreat Dis Int, 18, pp.576~579 (2019)
  31. Sokollik C, "Juvenile autoimmune hepatitis : a comprehensive review", J Autoimmun, 95, pp.69~76 (2018)
  32. Terziroli Beretta-Piccoli B, "Autoimmune sclerosing cholangitis : Evidence and open questions", J Autoimmun, 95, pp.15~25 (2018)
  33. Alswat K, "The spectrum of sclerosing cholangitis and the relevance of IgG4 elevations in routine practice", Am J Gastroenterol, 107, pp.56~63 (2012)
  34. Mendes FD, "Elevated serum IgG4concentration in patients with primary sclerosing cholangitis", Am J Gastroenterol, 101, pp.2070~2075 (2006)
  35. Bartholomew SV, "Lymphoplasmacytic sclerosing pancreatitis presenting as a pancreatic head mass in a child : case report and management recommendations", J Pediatr Surg, 41, pp.e23~e25 (2006)
  36. Blejter J, "Autoimmune pancreatitis : an adolescent case and review of literature", J Pediatr Surg, 43, pp.1368~1372 (2008)
  37. Friedlander J, "Diagnosis of autoimmune pancreatitis vs neoplasms in children with pancreatic mass and biliary obstruction", Clin Gastroenterol Hepatol, 10, pp.1051~1055 (2012)
  38. Gargouri L, "Recurrent autoimmune pancreatitis in a 10-year-old boy", J Pediatr Gastroenterol Nutr, 48, pp.374~377 (2009)
  39. Refaat R, "Autoimmune pancreatitis in an 11-year-old boy", Pediatr Radiol, 39, pp.389~392 (2009)
  40. Scheers I, "Autoimmune pancreatitis in children : characteristic features, diagnosis, and management", Am J Gastroenterol, 112, pp.1604~1611 (2017)
  41. Hart PA, "Editorial : autoimmune pancreatitis in children : is this a new subtype of disease or early-onset idiopathic duct-centric chronic pancreatitis", Am J Gastroenterol, 112, pp.1613~1614 (2017)
  42. Grammatikopoulos T, "Steroidresponsive autoimmune sclerosing cholangitis with liver granulocytic epithelial lesions", J Pediatr Gastroenterol Nutr, 56, pp.e3~e4 (2013)
  43. Zen Y, "Sclerosing cholangitis with granulocytic epithelial lesion : a benign form of sclerosing cholangiopathy", Am J Surg Pathol, 36, pp.1555~1561 (2012)
  44. Detlefsen S, "Sialadenitis in a patient with ulcerative colitis and autoimmune pancreatitis type 2", Pathol Res Pract, 216, pp.153072~ (2020)
  45. Ollo D, "Biliary involvement in type 2 autoimmune pancreatitis", Case Rep Gastroenterol, 13, pp.200~206 (2019)
  46. Detlefsen S, "Clinical features and relapse rates after surgery in type 1 autoimmune pancreatitis differ from type 2 : a study of 114 surgically treated European patients", Pancreatology, 12, pp.276~283 (2012)
  47. Maire F, "Outcome of patients with type 1 or 2 autoimmune pancreatitis", Am J Gastroenterol, 106, pp.151~156 (2011)
  48. Ku Y, "IL-8 expression in granulocytic epithelial lesions of idiopathic duct-centric pancreatitis(type 2 autoimmune pancreatitis)", Am J Surg Pathol, 41, pp.1129~1138 (2017)
  49. Chen Y, "Interleukin-8, a promising predictor for prognosis of pancreatic cancer", World J Gastroenterol, 18, pp.1123~1129 (2012)
  50. Gupta R, "Autoimmune pancreatitis type 2 : diagnostic utility of PD-L1 immunohistochemistry", Am J Surg Pathol, 43, pp.898~906 (2019)

관련 논문AI추천

Type 2 Autoimmune Pancreatitis (Idiopathic Duct-Centric Pancreatitis) Highlighting Patients Presenting as Clinical Acute Pancreatitis: A Single- Center Experience오동욱, Do Hyun Park, Dong Hui Cho, Dong-Wan Seo, Jin Hee Kim, Joo Nam Lee, Joune Seup Lee, Myung-Hwan Kim, Sang Soo Lee, Seok Jung Jo, Seung Mo Hong, Sung-Hoon Moon, Sung Koo Lee, Tae Jun Song거트앤리버 소화기연관학회협의회 · Gut and Liver2019 · 제13권 제4호Recent Advances in the Diagnosis and Management of Autoimmune Pancreatitis: Similarities and Differences in Japan and Korea김명환, 류지곤, 정재복, Kazuichi Okazaki, Terumi Kamisawa, Tooru Shimosegawa거트앤리버 소화기연관학회협의회 · Gut and Liver2013 · 제7권 제4호16세 청소년에서 발생한 2형 자가면역 췌장염김명환, 김소현, 김지훈, 김혜영, 백승호, 이세희, 최수진대한내과학회 · 대한내과학회지2020 · 제95권 제2호Idiopathic Duct Centric Pancreatitis in Korea: A Clinicopathological Study of 14 Cases강효정, 김지훈, 송태준, 유은실대한병리학회 · Journal of Pathology and Translational Medicine2011 · 제45권 제5호A Case of Autoimmune Pancreatitis Manifested by a Pseudocyst and IgG4- Associated CholangitisChang-Min Cho, Jong-Won Sohn, Min-Kyu Jung, Seong-Woo Jeon, Soo-Young Park거트앤리버 소화기연관학회협의회 · Gut and Liver2012 · 제6권 제1호Recent Advances in the Concept and Pathogenesis of IgG4-Related Disease in the Hepato-Bilio-Pancreatic SystemKazuichi Okazaki, Kazushige Uchida, Masahito Yanagawa, Toshiyuki Mitsuyama거트앤리버 소화기연관학회협의회 · Gut and Liver2014 · 제8권 제5호

이 간행물의 다른 논문 (20건)